Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy.

Morton, Lindsay M; Ricks-Santi, Luisel; West, Catharine M L; Rosenstein, Barry S

Morton, Lindsay M; Ricks-Santi, Luisel; West, Catharine M L; Rosenstein, Barry S.

Afiliação

Morton LM; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ricks-Santi L; Cancer Research Center, Hampton University, Hampton, VA, USA.
West CML; Division of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, United Kingdom.
Rosenstein BS; Department of Radiation Oncology and Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Int J Part Ther ; 5(1): 103-113, 2018.

Article em En | MEDLINE | ID: mdl-30505881

Palavras-chave

normal tissue toxicities; radiogenomics; second malignancies; single nucleotide polymorphisms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Part Ther Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google